Kerwin Espinosa hitman shot, critical

By: - Correspondent / @rdejonINQ
/ 11:57 AM November 09, 2018

Jaime Bisnar is being loaded to a stretcher so he could be brought to the hospital for treatment after he was shot by still unidentified assailants in Barangay Benolho, Albuera town, Leyte on Thursday morning. -Robert Dejon, Inquirer Visayas

ALBUERA, Leyte — One of the alleged hitmen of self-confessed drug lord Kerwin Espinosa was fighting for his life after he was shot on Thursday in Barangay Benolho here.

Jaime Bisnar, 47, was waiting for a ride when two men on board a motorcycle stopped in front of him about 9 a.m.


The back rider then got off from the motorcycle and fired at Bisnar before going back to his companion and sped off.

Bisnar was brought to a private hospital in nearby Ormoc City where he was in critical condition.


Senior Insp. Salvador Apacible Jr., acting Albuera police chief, said Bisnar used to be a hitman of Espinosa when the latter used to monopolize the drug operations in Eastern Visayas.

He said two Espinosa underlings had been killed since October this year.

Glenn Calunsag was abducted and found dead in Barangay Salvacion, Albuera, last Oct. 16.
Two days later, unknown assailants killed Jesus Tulin as well as his wife, Sunshine.

Read Next
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: drug lord, Jaime Bisnar, Kerwin Espinos, Local news, Philippine News, Salvador Apacible Jr., Shooting
For feedback, complaints, or inquiries, contact us.

‘La Llorona’: Horror’s unintended hilarity

April 27, 2019 12:25 AM


Atom Araullo examines ‘love scams’

April 27, 2019 12:20 AM


Indie drama highlights plight of leprosy survivors

April 27, 2019 12:15 AM

© Copyright 1997-2019 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.